Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 7Brain Neoplasms 4Pain 2Neuralgia 2Glioma 2Depression 2Visceral Pain 1Recurrence 1Rectal Neoplasms 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Lymphoma, Follicular 1Language Disorders 1Headache 1Glioblastoma 1Fatigue 1Depressive Disorder, Major 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1Cancer Survivor 1Anxiety Disorders 1Agnosia 1Acromegaly 1

Interventions

Temozolomide 3Irinotecan 3Bevacizumab 3Sorafenib 2Radiosurgery 2pembrolizumab 1ibrutinib 1Vorinostat 1Valproic Acid 1Transcranial Magnetic Stimulation 1Therapeutics 1Thalidomide 1Surveys and Questionnaires 1Standard of Care 1Sildenafil Citrate 1Radiotherapy 1Palliative Care 1Nivolumab 1Morphine 1Methadone 1Lenalidomide 1Laparoscopy 1Equipment and Supplies 1Eating 1Cytidine Triphosphate 1Bendamustine Hydrochloride 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurologic Manifestations × Transcranial Magnetic Stimulation × Clear all
NCT07530536 2026-04-15

rTMS for Postoperative Brain Tumor Patients

Columbia University

Phase NA Recruiting
6 enrolled
CNS

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡